Navigation Links
Wedgewood Pharmacy: U.S. Court of Appeals Vacates DEA Action
Date:12/12/2007

SWEDESBORO, N.J., Dec. 12 /PRNewswire/ -- Yesterday, the U.S. Court of Appeals for the District of Columbia Circuit vacated the Drug Enforcement Administration's (DEA) 2006 revocation of Wedgewood Pharmacy's registration to dispense controlled substances. Wedgewood has been challenging the DEA's decision since it first was issued.

The ruling consolidated two petitions: the company's appeal of the DEA's decision and the DEA's denial of Wedgewood's petition for reconsideration. The court explained that it does not set-aside Federal agency rulings "unless the interpretation is arbitrary, capricious, or manifestly contrary to the statute ... [and] if the agency ... entirely failed to consider an important aspect of the problem, offered an explanation for its decision that runs counter to the evidence before the agency, or is so implausible that it could not be ascribed to a difference in view or the product of agency expertise." The unanimous ruling, authored by Circuit Judge Karen LeCraft Henderson, noted "we cannot help but conclude that the DA's [DEA's Deputy Administrator] decision 'entirely failed to consider an important aspect of the problem,'" that is, "whether animal medicine operates differently from human medicine."

George J. Malmberg, R.Ph., F.A.C.A, F.A.C.V.P., the pharmacist president and CEO of Wedgewood Pharmacy, noted: "The Court made clear its concern that the practice of veterinary medicine differs from the practice of human medicine. We believe that the current standard of practice in our profession, which is to dispense controlled substances to veterinarians rather than to horse owners or stable personnel, is consistent with the law's intention to prevent the improper use of controlled substances. We look forward to having our registration restored by the DEA, though the timing of that will depend upon the agency's response to this ruling."

The DEA objected to Wedgewood's practice of preparing compounded controlled-substances and then delivering the medications to veterinarians and physicians instead of directly to their patients. DEA viewed these practices as "manufacturing" and "distributing" controlled substances as defined by the Controlled Substances Act. Under Wedgewood's then DEA-registration as a "practitioner," however, it was authorized only to "compound" and "dispense" controlled substances. Wedgewood argued that "dispensing" includes constructive delivery to an animal patient through a licensed veterinarian.

In vacating the revocation of Wedgewood's registration to dispense controlled substances, the court remanded the case to the DEA "for further proceedings consistent with this order," saying that the "DEA should clarify its interpretation of 'general office use,' 'order' and 'prescription'" and that the agency should "explain how the difference, if any, between the practices of human and veterinary medicine might affect its analysis."

Malmberg added, "This ruling tells us that we were correct in making arguments that the DEA rejected or ignored. We welcome the opportunity that this ruling now creates to arrive at a clear, sound understanding that works for all concerned. We want nothing more than to work cooperatively with DEA to resolve any issues it may still have with the current state of compounding- pharmacy practice in the veterinary profession."

The court decision is available at http://pacer.cadc.uscourts.gov/docs/common/opinions/200712/06-1156a.pdf.

About Wedgewood Pharmacy

Wedgewood Pharmacy is the largest veterinary compounding pharmacy in the United States, serving more than 20,000 prescribers of animal and human compounds. A compounding pharmacy creates customized medications for individual patients in response to a licensed practitioner's prescription.

Background: About Compounding

Because every patient is different and has different needs, customized, compounded medications are a vital part of quality medical care.

The basis of the profession of pharmacy has always been the "triad," the patient-physician-pharmacist relationship. Compounding is extremely important to the veterinary community, which often requires more flavors, dosages and strengths than commercially available medications supply. Through this relationship, patient needs are determined by a doctor, who chooses a treatment regimen that may include a compounded medication. Physicians and veterinarians often prescribe compounded medications for reasons that include (but are not limited to) the following situations:

-- When needed medications are discontinued by or generally unavailable

from pharmaceutical companies, often because the medications are no

longer profitable to manufacture;

-- When the patient is allergic to certain preservatives, dyes or binders

in available off-the shelf medications;

-- When treatment requires tailored dosage strengths for patients with

unique needs (for example, an infant);

-- When a pharmacist can combine several medications the patient is taking

to increase compliance;

-- When the patient cannot ingest the medication in its commercially

available form and a pharmacist can prepare the medication in cream,

liquid or other form that the patient can easily take; and

-- When medications require flavor additives to make them more palatable

for some patients, most often children and pets.

For additional information, visit the International Academy of Compounding Pharmacists' Web site at http://www.iacprx.org and http://www.compoundingfacts.org.

Marcy Kelly David Kirk, APR, Fellow PRSA

Vice President, Marketing davidkirk@thePRguy.com

mkelly@wedgewoodpharmacy.com 610.422.0048

856.832.1303


'/>"/>
SOURCE Wedgewood Pharmacy
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Wedgewood Pharmacy and Midwest Veterinary Supply Sign New Agency Agreement
2. Texas Supreme Court Rules Against Medicare HMOs in Hospital Reimbursement Fight
3. Claim Filed Against the Company and Nine Other Defendants in the Haifa Magistrates Court
4. First Circuit Court of Appeals Rules Against Philip Morris in Lights Class Action
5. Wyeth and Nycomed Announce Court Denial of Preliminary Injunction
6. Massachusetts State Court Hears Suit by Breastfeeding Mother on Medical Licensing Exam
7. Cristina Saralegui Joins Celebrities Including Matthew McConaughey, Courteney Cox and Mariska Hargitay to Raise Money for Breast Cancer Research
8. Filing for Reconsideration/Press Conference ACUNA v. TURKISH, Historic Informed Consent Abortion Case to the New Jersey Supreme Court
9. Rulings Send Lawsuits Against State Farm, American Family Back to Court, Hagens Berman Sobol Shapiro Announces
10. NBME Appeals Massachusetts Judges Reversal of Lower Court in Suit for Extra Break Time During Medical Licensing Exam
11. New Report Says Health Courts Bureaucracies Offer Big Financial Burdens and Loss of Patient Rights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, and ... in the eye of the beholder, according to experts who offered insights and commentary ... of Managed Care. For the full issue, click here . , For the ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Dialysis Devices Global Market - Forecast to 2022" report ... is the treatment method for the patients with kidney failure, ... and excess fluid from the patient,s blood and thus the ... sodium, potassium and chloride in balance. Increasing ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology: